144 related articles for article (PubMed ID: 9213167)
1. A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis.
Ayabe T; Ashida T; Taniguchi M; Nomura M; Einami K; Taruishi M; Saitoh Y; Santos SB; Ono M; Shibata Y; Kohgo Y
Intern Med; 1997 May; 36(5):322-6. PubMed ID: 9213167
[TBL] [Abstract][Full Text] [Related]
2. Centrifugal leukocyte apheresis for ulcerative colitis.
Ayabe T; Ashida T; Kohgo Y
Ther Apher; 1998 May; 2(2):125-8. PubMed ID: 10225713
[TBL] [Abstract][Full Text] [Related]
3. Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.
Okada H; Takenaka R; Hiraoka S; Makidono C; Hori S; Kato J; Okazaki H; Kawamoto H; Mizuno M; Shiratori Y
Ther Apher Dial; 2006 Jun; 10(3):242-6. PubMed ID: 16817788
[TBL] [Abstract][Full Text] [Related]
4. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
[TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis is effective in inducing but not in maintaining remission in ulcerative colitis.
Honma T; Sugimura K; Asakura H; Matsuzawa J; Suzuki K; Kobayashi M; Aoyagi Y
J Clin Gastroenterol; 2005; 39(10):886-90. PubMed ID: 16208112
[TBL] [Abstract][Full Text] [Related]
6. Steroid-sparing strategies in the management of ulcerative colitis: efficacy of leukocytapheresis.
Shiraki M; Yamamoto T
World J Gastroenterol; 2012 Nov; 18(41):5833-8. PubMed ID: 23139598
[TBL] [Abstract][Full Text] [Related]
7. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
[TBL] [Abstract][Full Text] [Related]
8. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
9. A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.
Yokoyama Y; Matsuoka K; Kobayashi T; Sawada K; Fujiyoshi T; Ando T; Ohnishi Y; Ishida T; Oka M; Yamada M; Nakamura T; Ino T; Numata T; Aoki H; Sakou J; Kusada M; Maekawa T; Hibi T
J Crohns Colitis; 2014 Sep; 8(9):981-91. PubMed ID: 24556083
[TBL] [Abstract][Full Text] [Related]
10. Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A.
Dittrich K; Richter M; Rascher W; Köhler H
Inflamm Bowel Dis; 2008 Oct; 14(10):1466-7. PubMed ID: 18421764
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting short- and long-term effects of leukocyte removal therapy in active ulcerative colitis.
Nakano R; Iwakiri R; Ikeda Y; Kishi T; Tsuruoka N; Shimoda R; Sakata Y; Yamaguchi K; Fujimoto K
J Gastroenterol Hepatol; 2013 Feb; 28(2):303-8. PubMed ID: 23339387
[TBL] [Abstract][Full Text] [Related]
13. Novel Leucocyte/Thrombocyte Apheresis for Induction of Steroid-Free Remission in Ulcerative Colitis: A Controlled Randomized Pilot Study.
Kruis W; Nguyen P; Morgenstern J; Ramlow W; Dignaß A; Stallmach A; Drebber U
J Crohns Colitis; 2019 Jul; 13(7):949-953. PubMed ID: 30863856
[TBL] [Abstract][Full Text] [Related]
14. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
[TBL] [Abstract][Full Text] [Related]
15. Ratio of platelet reduction is an early predictive factor for the effectiveness of leukocytapheresis for ulcerative colitis patients.
Takemoto K; Kuriyama M; Kato J; Suzuki H; Ishikawa S; Hiraoka S; Yamamoto K
Ther Apher Dial; 2009 Feb; 13(1):6-13. PubMed ID: 19379164
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
Yajima T; Takaishi H; Kanai T; Iwao Y; Watanabe M; Ishii H; Hibi T
Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
[TBL] [Abstract][Full Text] [Related]
18. Effective maintenance leukocytapheresis for patients with steroid dependent or resistant ulcerative colitis.
Kondo K; Shinoda T; Yoshimoto H; Takazoe M; Hamada T
Ther Apher; 2001 Dec; 5(6):462-5. PubMed ID: 11800081
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.
Hyams JS; Davis S; Mack DR; Boyle B; Griffiths AM; LeLeiko NS; Sauer CG; Keljo DJ; Markowitz J; Baker SS; Rosh J; Baldassano RN; Patel A; Pfefferkorn M; Otley A; Heyman M; Noe J; Oliva-Hemker M; Rufo P; Strople J; Ziring D; Guthery SL; Sudel B; Benkov K; Wali P; Moulton D; Evans J; Kappelman MD; Marquis A; Sylvester FA; Collins MH; Venkateswaran S; Dubinsky M; Tangpricha V; Spada KL; Britt A; Saul B; Gotman N; Wang J; Serrano J; Kugathasan S; Walters T; Denson LA
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):855-868. PubMed ID: 28939374
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of ulcerative colitis with leukocytapheresis using non-woven polyester filter.
Sakata H; Kawamura N; Horie T; Ohizumi H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Saitoh M; Kawamura A
Ther Apher Dial; 2003 Dec; 7(6):536-9. PubMed ID: 15018240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
